Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Ivarmacitinib may effectively treat complex atopic dermatitis and related hair loss.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

The rash resolved after stopping ponatinib.

Combining TCA with 5-FU is more effective and safer for treating keloids than TCA alone.

Both treatments help hair regrowth, with PRP being slightly better.

A 13-year-old girl with various symptoms was successfully treated with an antibiotic called co-trimoxazole.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Tofacitinib treatment is used for teenagers with alopecia areata.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Both concentrations of triamcinolone acetonide are effective for hair regrowth in patchy alopecia areata, but 5 mg/mL is recommended to reduce side effects.

JAK inhibitors can effectively regrow hair in alopecia areata patients, but ongoing treatment is needed to maintain results.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

Dupilumab can help hair regrowth but may also trigger alopecia areata.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.